TTX-030, budigalimab, nab-paclitaxel and gemcitabine

COMBINATION_PRODUCT2 trials

Sponsors

Trishula Therapeutics, Inc.

Conditions

Pancreatic CancerSolid Tumor, Adult

Phase 1

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

CompletedNCT04306900

Trishula Therapeutics, Inc.Solid Tumor, Adult

Start: 2020-03-30End: 2024-03-27Updated: 2025-07-29

Phase 2

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

CompletedNCT06119217

Trishula Therapeutics, Inc.Pancreatic Cancer

Start: 2024-03-25End: 2026-03-06Updated: 2026-05-13